Org.nr 815 643 062 2020 → 2021 Year-over-year analysis

ADESSO BIOPRODUCTS AS: årsregnskap 2021 vs 2020

Grew 27% on revenue, stronger earnings

approved 2022-04-19; registry 2022-05-11; journal 2022 219096

Summary

What changed

Comparing Årsregnskap 2021 with 2020 for ADESSO BIOPRODUCTS AS. Revenue 59.18m NOK → 74.98m NOK (+26.7%). Net result +2.88m NOK → +3.93m NOK.

On the constructive side: revenue rose; operating result improved; net result improved.

Also worth watching: cogs moved. All figures are taken from the published annual accounts for ADESSO BIOPRODUCTS AS.

At a glance

Revenue

59.18m NOK 74.98m NOK

+26.7%

Operating result

+4.17m NOK +5.15m NOK

+23.6%

Net result

+2.88m NOK +3.93m NOK

+36.3%

Cash

5.44m NOK 13.29m NOK

+144.5%

Total assets

57.30m NOK 81.18m NOK

+41.7%

↑
Revenue rose

Operating income / revenue moved from 59.18m NOK to 74.98m NOK (+26.7% YoY). Calculated
↑
Operating result improved

Operating result +4.17m NOK → +5.15m NOK (op. margin 7.0% → 6.9%). Calculated
↑
Net result improved

Net result +2.88m NOK → +3.93m NOK (net margin 4.9% → 5.2%). Calculated
↑
Cash rose

Bank deposits 5.44m NOK → 13.29m NOK (+144.5% YoY). Calculated

·
COGS moved

COGS / varekostnad 22.62m NOK → 37.47m NOK (+65.7% YoY). Calculated